Your session is about to expire
← Back to Search
Text Message Reminders for Cervical Cancer Screening
N/A
Waitlist Available
Led By David Adler, MD
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 150 days
Awards & highlights
Summary
This trial will test whether text message reminders can help women keep up with recommended cervical cancer screenings.
Who is the study for?
This trial is for English, Spanish, or ASL-speaking women aged 21-65 who can make their own medical decisions. It's not for those without a cervix due to surgery like hysterectomy, HIV-positive individuals (due to different screening needs), or anyone unable to consent at the time.Check my eligibility
What is being tested?
The study tests if text message prompts can help more women visiting the emergency department get screened for cervical cancer. The goal is to see if mobile technology can improve screening rates among patients.See study design
What are the potential side effects?
Since this intervention involves sending SMS prompts and does not include medication or invasive procedures, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 150 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~150 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Rate of screening for cervical cancer
Secondary outcome measures
Self-administered vs in-person baseline technique
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Self-Administered TreatmentExperimental Treatment1 Intervention
Treatment group (receives text messages), initial screening measures conducted on their own via an iPad.
Group II: In-person TreatmentExperimental Treatment1 Intervention
Treatment group (receives text messages), initial screening measures conducted in-person in the Emergency Department.
Group III: in-person controlActive Control1 Intervention
Usual care, initial screening measures conducted in-person in the Emergency Department.
Group IV: Self-Administered ControlActive Control1 Intervention
Usual care, initial screening measures conducted on their own via an iPad.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SMS-intervention
2020
N/A
~1120
Find a Location
Who is running the clinical trial?
University of RochesterLead Sponsor
847 Previous Clinical Trials
534,281 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,748 Previous Clinical Trials
40,958,285 Total Patients Enrolled
David Adler, MDPrincipal Investigator - University of Rochester
Strong Memorial Hospital
University Of California (Medical School)
Alameda Co Medical Center (Residency)
1 Previous Clinical Trials
303 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are a woman.If you are a transwoman and have had surgery to remove your cervix, you cannot participate in this trial.
Research Study Groups:
This trial has the following groups:- Group 1: In-person Treatment
- Group 2: in-person control
- Group 3: Self-Administered Control
- Group 4: Self-Administered Treatment
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger